After The Run Up There's Still Double Digit Return Potential For Johnson & Johnson

When you think of some of the greatest companies in the world one name that is sure to come up is Johnson & Johnson (NYSE:JNJ). What's not to like about a company that has earned investors 8.0% annualized total returns over the last decade, 10.8% annualized returns over the last 20 years, and 15.0% annualized returns over the last 30 years. Every dollar invested 30 years ago has turned into $66.21 today. There's very few companies that can match Johnson & Johnson's historic returns. Even more impressive is the 53 consecutive years of growing the dividend. Johnson & Johnson is clearly in very rare territory and has made long term investors very wealthy.

All those years of growth for Johnson & Johnson have grown the company into a $279 B behemoth in the healthcare industry. Johnson & Johnson is unlikely to continue providing double digit annual growth in the company mainly due to their large size.

Shares represented a good opportunity between late August and mid October when they traded in the low $90's. However, since then shares are now trading hands for $101.03. So what kind of returns could you expect if you buy shares today after the recent run-up.

Continue reading the quick Johnson & Johnson stock analysis on Seeking Alpha.

For more detailed analyses check out my Stock Analysis page.

Image sourced from JNJ.com